Pediatrix Medical Group MD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | 10.9%— | —— | —— | 8.8%-1.9pp | |
| Net margin | 8.6%— | —— | -3%-6.4pp | 3.4%-3.5pp | |
| Returns | |||||
| Return on equity | 20.3%— | —— | -6.9%-14.4pp | 7.4%-8.5pp | |
| Return on invested capital | 13.7%— | —— | -0.6%-12.8pp | 12.1%— | |
| Efficiency | |||||
| Asset turnover | 0.9×-0.1× | 0.9×0.0× | 0.9×+0.1× | 0.8×+0.1× | |
| Liquidity | |||||
| Current ratio | 1.7×+0.2× | 1.5×+0.2× | 1.2×+0.2× | 1×-1.0× | |
| Leverage | |||||
| Debt-to-equity | 0.7×-0.1× | 0.9×0.0× | 0.8×0.0× | 0.8×+0.7× | |
| Net debt / EBITDA | 1.1×— | —— | 24.3×+20.9× | 3.4×+4.7× | |
| Per Share | |||||
| Book value per share | $10.14+10.4% | $9.18-11.1% | $10.33-2.6% | $10.60+1.5% | |
| Valuation | |||||
| Market capitalization | $1.84B+63.0% | $1.13B+44.2% | $781.37M-36.6% | $1.23B-46.5% | |
| Price / earnings | 11.1×— | —— | —— | 18.6×+1.0× | |
| Price / sales | 1×+0.4× | 0.6×+0.2× | 0.4×-0.2× | 0.6×-0.6× | |
| Price / book | 2.1×+0.6× | 1.5×+0.6× | 0.9×-0.5× | 1.4×-1.2× | |
| EV / EBITDA | 9.1×— | —— | 54.1×+44.8× | 9.3×+0.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Pediatrix Medical Group's ratios come from?
- Every ratio is computed from Pediatrix Medical Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
